In the State of Alaska, to be eligible for ADAP enrollment, an individual must meet the following criteria:
a. Documented HIV positive status
b. Residency in the State of Alaska
- Residing in Alaska for a minimum of 30 days
- Willing to sign an "intent to Stay" letter
c. Income eligibility
- Income less than or equal to 400% of the Federal Poverty Level of Alaska for the applicable family size
- Non-income assets that fall within the level allowed for Medicaid eligibility
d. Be prescribed a medication on the ADAP formulary by an Alaska physician
e. Be an active client of one of the State-funded HIV Care Consortium lead agencies. Currently, these agencies include the Alaskan AIDS Assistance Association (Four A's) and the Interior AIDS Association (IAA).
The ADAP is required by federal law to be the "payer of last resort." The ADAP may not provide to an individual who is eligible for Medicaid or other Public Assistance, or who has private insurance or Veterans Administration benefits, any benefits that could be covered by the non-ADAP payer.
An individual enrolled in the ADAP must provide the Four A's ADAP administrator the information and documentation necessary to determine financial eligibility for the ADAP on an annual basis in order to remain enrolled (annual recertification). The Four A's may request updated documentation of financial eligibility at any time there is indication that information currently on file has changed.
An individual may self-refer to the ADAP (and become a client) at the Four A's or be referred to the ADAP by another agency. ADAP eligibility must be determined by a representative of the contract administrative agency (the Four A's). To be considered, each applicant must complete:
- An "ADAP Intake" form
- A Four A's (as administrative entity) "Release of Information" form
- Income verification for 3 recent months or the current tax return
All applications are reviewed and eligibility is determined by the Four A's ADAP administrator.
State covers some form of HCV drug therapies as part of their approved drug formularies: Yes
To learn more about what HCV drug therapies are on the drug formulary, please visit tiicann.org/co-infection-watch.html (go to page #7).